Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Compagnie Nationale à Portefeuille (CNP) is a prominent Belgian-Luxembourgish investment holding company owned by the Frère family. While it is a diversified investment firm, it maintains a significant presence in the life sciences and healthcare sectors through strategic equity stakes in major pharmaceutical and biotechnology companies. CNP operates as a long-term partner for its portfolio companies, providing capital and strategic guidance to drive growth and innovation. Its healthcare-related activities are primarily conducted through its investment vehicles, including its major shareholding in Groupe Bruxelles Lambert (GBL), which in turn holds significant positions in various healthcare and life science entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CNP Luxembourg.